Q-Line Biotech Limited (NSE:QLINE)

Q-Line Biotech Revenue

In the fiscal year ending March 31, 2026, Q-Line Biotech had annual revenue of 3.42B INR with 9.13% growth. Q-Line Biotech had revenue of 1.09B in the quarter ending March 31, 2026. That makes Q-Line Biotech the 30,148th largest company in the world by revenue and 2,122nd in India.

• Revenue: 3.42B
• Revenue Growth: +9.13%
• P/S Ratio: 3.53
• Revenue / Employee: 9.57M
• Employees: 357
• Market Cap: 12.05B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Manufacturing 2.30B 67.4%
• Trading 1.12B 32.6%

Fiscal year ended Mar 31, 2026 See the full Q-Line Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.42B	285.92M	9.13%
Mar 31, 2025	3.13B	1.09B	53.77%
Mar 31, 2024	2.04B	209.10M	11.44%
Mar 31, 2023	1.83B	-1.21B	-39.92%
Mar 31, 2022	3.04B	1.33B	77.46%

Data Source: S&P Global Market Intelligence Last updated: Sep 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error